CASC3 and Miyoshi myopathy: To validate the potential BTZ-resistance of SC2 cells, we also analyzed independent scRNA-seq data from a primary MM patient and confirmed that existence of SC2 cells (Supplementary Fig. 22a-d, Supplementary Note 4).